Author Archives: Micah Berman

Taking the “Scientific” and “Advisory” out of the EPA Scientific Advisory Board

by Micah Berman — Monday, Dec. 1, 2014

On November 18, the U.S. House voted (mostly on partly lines) to pass the EPA Science Advisory Board Act of 2014. Although the name of the Act is pretty dull, its impact would be significant. Among other problems, the bill would make the EPA Science Advisory Board (SAB) less scientific, and it would prohibit it […]

Bridging the Gap Between Science and Law

by Micah Berman — Wednesday, Oct. 22, 2014

I recently returned from the 2014 Public Health Law Conference, a fantastic event held every two years in Atlanta and hosted by the Network for Public Health Law, the American Society of Law, Medicine and Ethics, and the Robert Wood Johnson Foundation.  Presentations at the conference covered a wide range of issues from Ebola (the […]

Cost-Benefit Analysis, the FDA, and Tobacco

by Micah Berman — Tuesday, Sept. 16, 2014

I’m very pleased to be joining this blog as well.  I’ll blog about my area of interest – public health – with a focus on regulatory law and policy.  My specific area of expertise is tobacco policy, and as the FDA’s Center for Tobacco Products continues its efforts to regulate tobacco (and continues to get […]